Glycaemic Efficacy And Safety Of Ertugliflozin In Patients With Type 2 Diabetes And Stage 3 Chronic Kidney Disease: An Analysis From Vertis Cv

DIABETOLOGIA(2021)

Cited 8|Views10
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined